CN · Field Sheet
FIELD SHEET — FLAXSEED MFI-FLAXSE-20261019-FS
Survey index / FLAXSEED

Flaxseed.

Linum usitatissimum
Linseed; lignan, omega-3 and cardiometabolic literature.
SEALED MFI-FLAXSE-20261019-FS · RELEASED 2026-10-19
SHEET FINGERPRINTMFI-FLAXSE-20261019-FS
640INCLUDED
1,976EXCLUDED
82DUPLICATE
136NON-TRANSFERABLE
0OUT OF CUTOFF
Survey totalsScroll ↓
2,834records surveyed
640studies
38claims graded
283observations
10,659graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-f025470de7ef35b7GRADE VERY_LOW
flaxseed constituents — cholesterol
direction BENEFIT · dose 100 mg/kg; 1000 mg/kg; 40 g/kg · duration 13 days; 21 days; 23 weeks; 3 months; 30 days; 6 months; 8 weeks
Grade basis — weakest-link ceilings
MODERATEdesign
LOWdirectness
VERY_LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
28bound studies
Bound studies (4 shown of 28)
STU-129e5ce06057d93a
RCT · HUMAN · 2023 · RoB SOME_CONCERNS
5 endpoints
STU-17a4ed254ce151aa
ANIMAL · ANIMAL · 2024 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-1a36d3d458d80c8c
ANIMAL · ANIMAL · 2025 · 3 months · RoB INSUFFICIENT_INFORMATION
5 endpoints
STU-2d3050730004f7ff
ANIMAL · ANIMAL · 2025 · RoB INSUFFICIENT_INFORMATION
6 endpoints
Quantitative observations
observation 100 mg/kg · validated
observation 40 g/kg · validated
observation 3 months · failed extraction
Opposition screen
SCREEN · 60 candidates considered · 3 bound as opposing
SYNTHESIS SYN-f7351b53903667 — outcome QUALITATIVE_ONLY · BENEFIT ×28 · not_assessed_quantitatively · 28 members
PROVENANCE → epmc:36818058, epmc:38167049, epmc:39797657 · PKG f44c4e63e1a0bf06…
CLAIM · CLM-81d96664e5030fe9GRADE VERY_LOW
flaxseed constituents — antioxidant
direction BENEFIT · dose 200 mg/kg; 5 g/kg · duration 3 months; 30 days; 4 weeks; 8 weeks
Grade basis — weakest-link ceilings
HIGHdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
25bound studies
Bound studies (4 shown of 25)
STU-129e5ce06057d93a
RCT · HUMAN · 2023 · RoB SOME_CONCERNS
5 endpoints
STU-1951e176bcc96945
ANIMAL · ANIMAL · 2024 · RoB INSUFFICIENT_INFORMATION
1 endpoints
STU-1a00784420cf4d24
ANIMAL · ANIMAL · 2023 · RoB SOME_CONCERNS
3 endpoints
STU-1a36d3d458d80c8c
ANIMAL · ANIMAL · 2025 · 3 months · RoB INSUFFICIENT_INFORMATION
5 endpoints
Quantitative observations
observation 200 mg/kg · validated
observation reduced the incidence of diabetes using serum glucose levels · failed extraction
observation 24 · validated
Opposition screen
SCREEN · 47 candidates considered · 3 bound as opposing
SYNTHESIS SYN-9ac8cfe39bea9c — outcome QUALITATIVE_ONLY · BENEFIT ×25 · not_assessed_quantitatively · 25 members
PROVENANCE → epmc:36818058, epmc:40454362, epmc:37640806 · PKG f44c4e63e1a0bf06…
Bounded preview — representative records only. The full release ships 38 claims and 283 observations.